FDA Inspection 1141685 — Syngene USA Inc.
The FDA completed an inspection of Syngene USA Inc. on April 20, 2021 in Baltimore, MD. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Biologics.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- April 20, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Baltimore, MD (United States)